What does MassPAT require prescribers to do before issuing a prescription for narcotic drugs?

What does MassPAT require prescribers to do before issuing a prescription for narcotic drugs?

• A. Utilize an online Prescription Monitoring Program
• B. Check a patient's insurance
• C. Consult with a pharmacist
• D. File a report with the Board

Answer: (A)

MassPAT, which stands for the Massachusetts Prescription Awareness Taskforce, mandates that prescribers utilize an online Prescription Monitoring Program (PMP) before issuing prescriptions for narcotic medications. This requirement is designed to enhance patient safety and prevent prescription drug abuse by ensuring that providers have access to a patient's prescription history. By checking the PMP, prescribers can determine if a patient has received narcotic prescriptions from multiple providers or is potentially misusing their medications. This requirement underscores the state's commitment to responsible prescribing practices and the prevention of substance misuse. While checking a patient's insurance, consulting with a pharmacist, and filing a report with the Board may be relevant steps in the prescribing process in other contexts, they do not meet the specific legal obligation outlined by MassPAT related to the use of the Prescription Monitoring Program.

MassPAT, which stands for the Massachusetts Prescription Awareness Taskforce, mandates that prescribers utilize an online Prescription Monitoring Program (PMP) before issuing prescriptions for narcotic medications. This requirement is designed to enhance patient safety and prevent prescription drug abuse by ensuring that providers have access to a patient's prescription history. By checking the PMP, prescribers can determine if a patient has received narcotic prescriptions from multiple providers or is potentially misusing their medications. This requirement underscores the state's commitment to responsible prescribing practices and the prevention of substance misuse.

While checking a patient's insurance, consulting with a pharmacist, and filing a report with the Board may be relevant steps in the prescribing process in other contexts, they do not meet the specific legal obligation outlined by MassPAT related to the use of the Prescription Monitoring Program.